Skip to content
Register Now

UPCOMING WEBINAR | REGISTER TODAY

Rethinking MES in Pharma: Faster Reviews, Better Data, Less Risk

Thursday 21 August, 2PM SGT

Pharma and biotech manufacturing are evolving fast. From scaling new therapies to responding to global health events, manufacturers face growing pressure to move faster while maintaining full compliance.

But traditional MES systems struggle to keep up — especially in environments with complex genealogy, personalized therapies, and constant regulatory shifts.

Register for this webinar to see how a composable approach to MES gives pharma manufacturers the flexibility to adapt quickly, enforce SOPs, and maintain data integrity — all while empowering frontline teams to build workflows tailored to their operations.


We will talk about:

  • What’s Driving Change: FDA digital compliance guidance, rising demand for personalized therapies, and the need to scale rapidly in response to new indications

  • Core Traits of Composable MES: What makes a system truly composable — and where legacy platforms fall short

  • How to Build It Right: Streamline operations with guided workflows, automated audit trails, and just-in-time training

  • Proof in Practice: Real-world results from pharma manufacturers improving speed, quality, and adaptability with composable systems

Whether you're navigating regulatory complexity, preparing for rapid scale-up, or modernizing legacy systems, this session will help you reframe how MES can work for today’s pharma environment.

Register for the webinar today!

Featuring:

  • Olivier Neron

    Global Head of Life Sciences Practice, Tulip

  • João Aido

    Digital Transformation Engineer, Tulip